Episodi

  • The Science of SGLT1 and SGLT2: Unpacking Dual Inhibition for Heart Failure
    Apr 13 2026

    Sodium-glucose cotransporter 2 (SGLT2) inhibitors transformed HF care. Meet SGLT1, a transporter that may unlock even greater CV protection.

    Credit available for this activity expires: 4/10/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/science-sglt1-and-sglt2-unpacking-dual-inhibition-heart-2026a1000axj?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    17 min
  • Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach
    Mar 30 2026

    Intervening early can stop metabolic dysfunction-associated steatohepatitis (MASH) progressing to fibrosis. Which of your patients with type 2 diabetes (T2D) or obesity need treatment, and what therapies are available?

    Credit available for this activity expires: 3/26/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/liver-fibrosis-type-2-diabetes-and-obesity-case-based-2026a10008y0?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    21 min
  • Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer
    Mar 23 2026

    Where do PI3K/AKT pathway inhibitors fit in the modern treatment landscape of breast cancer?

    Credit available for this activity expires: 3/19/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    36 min
  • New Horizons in Uveitic Macular Edema
    Mar 18 2026

    Do you know when to suspect edema in uveitis and how to manage it?

    Credit available for this activity expires: 3/18/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-horizons-uveitic-macular-edema-2026a10007ij?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    34 min
  • Metabolic Crossroads: Navigating the Obesity–Liver Disease Axis
    Mar 18 2026

    Do you know how to optimally identify, risk stratify, and treat your patients with obesity and MASLD or MASH?

    Credit available for this activity expires: 03/17/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/metabolic-crossroads-navigating-obesity-liver-disease-axis-2026a10007kf?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    51 min
  • Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines
    Mar 11 2026

    What clinical trials led to updates in the treatment strategies for advanced/recurrent endometrial cancer?

    Credit available for this activity expires: 3/9/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-update-advanced-recurrent-endometrial-cancer-how-2026a10006up?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    37 min
  • Beyond PSMA: Preparing Your Practice for the Next Wave of Prostate Cancer Biomarkers
    Mar 10 2026

    Are you up to speed on emerging biomarkers? Join our expert panel to learn more about their clinical relevance and testing best practices

    Credit available for this activity expires: 3/6/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-psma-preparing-your-practice-next-wave-prostate-2026a10006ql?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    31 min
  • Avoiding Common Mistakes in Managing Focal Epilepsy
    Mar 5 2026

    Do you know how many seizures is too many? Or what drugs to avoid in older epilepsy patients?

    Credit available for this activity expires: 3/3/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/avoiding-common-mistakes-managing-focal-epilepsy-2026a10004kv?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    19 min